1329PEfficacy and safety of vandetanib for patients with advanced and progressive medullary thyroid cancer (MTC) as systemic treatment beyond first-line therapy. (23rd October 2018) - Hernando Cubero, J; Grande, E; Jimenez Fonseca, P; Villabona, C; Trigo Perez, J M; Martinez Trufero, J; Pajares Bernad, I; Lopez, C; Alonso, T; Biarnes, J; Ramón, T; Cajal, Y; et al.